We are live on
!
Find out more
Caption Management Portfolio holdings
AUM
$21.5B
Turnover
58.11%
1-Year Est. Return
81.81%
This Fund
S&P 500
This Quarter
Est. Return
-0.74%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
–
AUM
$17.1B
AUM Growth
+$2.54B
(+17%)
Cap. Flow
-$40.7M
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
2,194
New
682
Increased
333
Reduced
357
Closed
710
Avg Time Held Equity + Options
0.4
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.1
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blue Owl Capital
OWL
|
+$166M |
| 2 |
Meta Platforms (Facebook)
META
|
+$72.1M |
| 3 |
NVIDIA
NVDA
|
+$63.6M |
| 4 |
Take-Two Interactive
TTWO
|
+$56.8M |
| 5 |
Global X Cybersecurity ETF
BUG
|
+$23.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$128M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$124M |
| 3 |
Netflix
NFLX
|
+$48.3M |
| 4 |
Microsoft
MSFT
|
+$33M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$31.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 88.8% |
| 2 | Technology | 2.44% |
| 3 | Healthcare | 2.37% |
| 4 | Consumer Discretionary | 1.9% |
| 5 | Financials | 1.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1301
nLIGHT
LASR
$2.01B
| $285K | ﹤0.01% |
+5,000
| New | +$271K |
2026 Q1
0 quarters
|
|
1302
iShares MSCI South Korea ETF
EWY
$21.9B
| $283K | ﹤0.01% |
2,300
-3,100
| -57% | -$388K |
2025 Q4
1 quarter
|
|
1303
Legend Biotech
LEGN
$3.73B
| $280K | ﹤0.01% |
+15,500
| New | +$295K |
2026 Q1
0 quarters
|
|
1304
Aldeyra Therapeutics
ALDX
$40.3M
| $279K | ﹤0.01% |
165,000
+130,000
| +371% | +$570K |
2025 Q4
1 quarter
|
|
1305
SL Green Realty
SLG
$3.37B
| $277K | ﹤0.01% |
+7,500
| New | +$312K |
2026 Q1
0 quarters
|
|
1306
Daqo New Energy
DQ
$719M
| $277K | ﹤0.01% |
+13,000
| New | +$317K |
2026 Q1
0 quarters
|
|
1307
Cadiz
CDZI
$328M
| $270K | ﹤0.01% |
55,000
-207,345
| -79% | -$1.13M |
2025 Q3
2 quarters
|
|
1308
CALL
Cabaletta Bio
CABA
$256M
| $269K | ﹤0.01% |
+100,000
| New | +$278K |
2026 Q1
0 quarters
|
|
1309
PennyMac Financial
PFSI
$3.22B
| $267K | ﹤0.01% |
3,060
| – | – |
2025 Q3
2 quarters
|
|
1310
T1 Energy
TE
$830M
| $267K | ﹤0.01% |
+60,900
| New | +$446K |
2026 Q1
0 quarters
|
|
1311
CALL
ImmunityBio
IBRX
$10.5B
| $261K | ﹤0.01% |
+34,000
| New | +$233K |
2026 Q1
0 quarters
|
|
1312
CALL
PepGen
PEPG
$180M
| $257K | ﹤0.01% |
+145,200
| New | +$816K |
2026 Q1
0 quarters
|
|
1313
International Money Express
IMXI
$330M
| $254K | ﹤0.01% |
+16,100
| New | +$252K |
2026 Q1
0 quarters
|
|
1314
CALL
Xponential Fitness
XPOF
$194M
| $254K | ﹤0.01% |
42,200
-619,800
| -94% | -$4.48M |
2023 Q1
12 quarters
|
|
1315
PUT
F&G Annuities & Life
FG
$2.59B
| $253K | ﹤0.01% |
+10,000
| New | +$261K |
2026 Q1
0 quarters
|
|
1316
Heron Therapeutics
HRTX
$73.1M
| $251K | ﹤0.01% |
+313,681
| New | +$363K |
2026 Q1
0 quarters
|
|
1317
CALL
Invesco Solar ETF
TAN
$878M
| $251K | ﹤0.01% |
4,500
-72,200
| -94% | -$4M |
2025 Q2
3 quarters
|
|
|
1318
PUT
Invesco Solar ETF
TAN
$878M
| $251K | ﹤0.01% |
4,500
-45,500
| -91% | -$2.52M |
2024 Q4
5 quarters
|
|
1319
Perspective Therapeutics
CATX
$264M
| $250K | ﹤0.01% |
+60,000
| New | +$253K |
2026 Q1
0 quarters
|
|
1320
JBS N.V.
JBS
$42.6B
| $246K | ﹤0.01% |
13,700
+900
| +7% | +$14K |
2025 Q3
2 quarters
|
|
1321
CALL
Satellogic
SATL
$630M
| $245K | ﹤0.01% |
+45,000
| New | +$166K |
2026 Q1
0 quarters
|
|
1322
CALL
Upwork
UPWK
$1.1B
| $241K | ﹤0.01% |
22,000
-58,000
| -73% | -$913K |
2025 Q4
1 quarter
|
|
1323
Woodside Energy
WDS
$44.2B
| $239K | ﹤0.01% |
+10,000
| New | +$194K |
2026 Q1
0 quarters
|
|
1324
CALL
Evolus
EOLS
$493M
| $238K | ﹤0.01% |
+58,000
| New | +$281K |
2026 Q1
0 quarters
|
|
1325
QXO Inc
QXO
$11.6B
| $237K | ﹤0.01% |
+12,200
| New | +$279K |
2026 Q1
0 quarters
|
|
Similar funds
Caption Management's Q1 2026 Portfolio in Review
As of Q1 2026, Caption Management held 2,194 positions worth $17.1B, up 17% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Caption Management's Q1 2026 filing shows 682 new, 333 increased, 357 reduced and 710 closed positions. Its largest new stake was Meta Platforms (Facebook): 112,500 shares worth $64.4M. The largest sale was Apple, an estimated $128M.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 85% a quarter earlier, followed by Technology and Healthcare.
- Caption Management's largest Q1 2026 buy was Meta Platforms (Facebook): 112,500 shares worth $64.4M.
- Caption Management added most to Blue Owl Capital in Q1 2026, an estimated $166M increase.
- Caption Management's biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $124M.
- Caption Management fully exited Apple in Q1 2026, selling an estimated $128M.
- Caption Management's ten largest holdings make up 22% of its $17.1B portfolio in Q1 2026.
- Caption Management opened 682 new positions and closed 710 in Q1 2026.
- Caption Management's portfolio value rose 17% quarter-over-quarter to $17.1B.
Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.